The VISKA Approach

At Viska Bio, we are pioneering a modular platform of novel fusion proteins designed to drive anti-tumor immunity by modulating and mimicking immune responses to immunogenic cell death (ICD). This adaptable approach engages both innate and adaptive immunity, expanding precision oncology beyond traditional targets to eliminate cancer and prevent recurrence.